Injured? Dial #WIN or #946 from your cellphone for your free consultation or call 1-800-LAW-NEED.
Call Us 24/7
1-800-LAW-NEED
( 1-800-529-6333 )

Zantac Recalled at Walmart, Rite Aid, and Walgreens Due to Cancer Concerns


October 03, 2019

WASHINGTON, D.C. — The U.S. Food and Drug Administration found potential cancer-causing agents in Ranitidine tablets. Apotex, the company that manufactures Ranitidine tablets for retail stores, will join with the FDA by announcing a recall of its products. Ranitidine is a stomach acid reducer. Most people recognize Ranitidine by its brand name Zantac. However, the USA Today reported that the generic or store brand forms of Zantac sold by Walgreen, Rite Aid, and Walmart, respectively, will be recalled by the stores because of the presence of a suspected carcinogen called NDMA. *

The so-called “chain pharmacies” sell the recalled Ranitidine products over the counter. There was no information provided whether any pharmaceutical companies would recall their prescription Ranitidine medications from Walmart, Walgreens, or Rite Aid, even though some companies have announced presumption recalls. All three retail outlets are recalling doses they sell in 75 mg and 150 mg. Walmart markets its store brand version of Ranitidine as Wal-Zan. Both Walgreens and Rite Aid use the generic name Ranitidine in the product name. 

Earlier in the week, Sandoz, a pharmaceutical company owned by Novartis, announced a recall of its 30, 50, and 500-count bottles of Ranitidine capsules that are available by prescription only. Sandoz’ Ranitidine capsules are prescribed to treat acids reflux and ulcers. The company also announced that it would cease its shipments of those medications due to the potential contamination by NDMA.

GlaxoSmithKline announced that it would recall Ranitidine medications from India as well as Hong Kong. Although a British company that does market pharmaceuticals in the U.S., it does not sell Ranitidine products in the States.

The levels of the suspected carcinogenic compound NDMA found in the recalled products is very low. However, the quantity of NDMA found in the tested samples exceeds the FDA’s allowable volume of consumption of NDMA. The presence of NDMA has also led to the recall of some blood pressure and heart medicine known as losartan. 

At Montlick & Associates, We Know What it Takes to Win™ Product Liability Cases.  

If you or a family member has suffered an ailment, cancer or if you lost a loved one due to a defective medication, contact Montlick and Associates, Attorneys at Law, today for your Free Consultation with our Product Liability Attorneys.  You may be entitled to valuable compensation, including compensation for medical expenses, lost wages, Pain and Suffering, and more. Call us nationwide toll-free, 24 hours a day, 7 days a week at 1-800-LAW-NEED (1-800-529-6333), or by dialing #WIN (#946) from your cell phone. Or feel free to visit us visit us online at www.montlick.com and complete our Free Case Evaluation Form or our 24-hour live Online Chat.

Source:https://www.usatoday.com/story/news/nation/2019/09/26/novartis-and-glaxosmithkline-recall-versions-generic-zantac/3773028002/

Category: Product Liability

Please Note:
Many of our blog articles discuss the law. All information provided about the law is very general in nature and should not be relied upon as legal advice. Every situation is different, and should be analyzed by a lawyer who can provide individualized advice based on the facts involved in your unique situation, and a consideration of all of the nuances of the statutes and case law that apply at the time.